Human papillomavirus vaccine knowledge and hypothetical acceptance among women in Appalachia Ohio

Vaccine

Volumn 30, Issue 36, 2012, Pages 5349-5357

  Ruffin, Mack T ^a   Hade, Erinn M ^b   Gorsline, Melissa R ^c   DeGraffinreid, Cecilia R ^c   Katz, Mira L ^c   Kobrin, Sarah C ^d   Paskett, Electra D ^e  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c OHIO STATE UNIVERSITY   (United States)

^d NATIONAL CANCER INSTITUTE   (United States)

^e THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

Attitude to health; Human papillomavirus; Papillomavirus vaccines; Rural population; Women

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; ATTITUDE TO HEALTH; CANCER IMMUNIZATION; CANCER PREVENTION; DAUGHTER; FEMALE; HEALTH SURVEY; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; UNITED STATES;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; OHIO; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT ACCEPTANCE OF HEALTH CARE; QUESTIONNAIRES; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84863992669     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.06.034     Document Type: Article

References (41)

1. Dunne E.F., Unger E.R., Sternberg M., McQuillan G., Swan D.C., Patel S.S., et al. Prevalence of HPV infection among females in the United States. JAMA 2007, 297:813-819.
2. Walboomers J.M., Jacobs M.V., Manos M.M., Bosch F.X., Kummer J.A., Shah K.V., et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999, 189:12-19.
3. Lacey C.J., Lowndes C.M., Shah K.V. Chapter 4: burden and management of non-cancerous HPV-related conditions: HPV-6/11 disease. Vaccine 2006, 24(Suppl. 3):S35-S41.
4. Villa L.L., Costa R.L., Petta C.A., Andrade R.P., Ault K.A., Giuliano A.R., et al. Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial. Lancet Oncol. 2005, 6:271-278.
5. Giuliano A.R., Palefsky J.M., Goldstone S., Moreira E.D., Penny M.E., Aranda C., et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N. Engl. J. Med. 2011, 364:401-411.
6. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the advisory committee on immunization practices (ACIP). MMWR Recomm. Rep. 2007, 56:1-24.
7. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2010, 59:630-632.
8. FDA licensure of bivalent human papillomavirusvaccine (HPV2Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). Morb. Mortal. Wkly Rep. 2010, 59:626-629.
9. Brabin L., Roberts S.A., Kitchener H.C. A semi-qualitative study of attitudes to vaccinating adolescents against human papillomavirus without parental consent. BMC Public Health 2007, 7:20.
10. Constantine N.A., Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J. Adolesc. Health 2007, 40:108-115.
11. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J. Adolesc. Health 2005, 37:502-510.
12. Marlow L.A., Waller J., Wardle J. Trust and experience as predictors of HPV vaccine acceptance. Hum. Vaccin. 2007, 3:171-175.
13. Olshen E., Woods E.R., Austin S.B., Luskin M., Bauchner H. Parental acceptance of the human papillomavirus vaccine. J. Adolesc. Health 2005, 37:248-251.
14. Waller J., McCaffery K., Forrest S., Szarewski A., Cadman L., Austin J., et al. Acceptability of unsupervised HPV self-sampling using written instructions. J. Med. Screen. 2006, 13:208-213.
15. Zimet G.D. Improving adolescent health: focus on HPV vaccine acceptance. J. Adolesc. Health 2005, 37:S17-S23.
16. Dorell C.G., Yankey D., Santibanez T.A., Markowitz L.E. Human papillomavirus vaccination series initiation and completion, 2008-2009. Pediatrics 2011, 128:830-839.
17. Ferris D.G., Cromwell L., Waller J.L., Horn L. Most parents do not think receiving human papillomavirus vaccine would encourage sexual activity in their children. J. Low Genit. Tract Dis. 2010, 14:179-184.
18. Katz M.L., Reiter P.L., Heaner S., Ruffin M.T., Post D.M., Paskett E.D. Acceptance of the HPV vaccine among women, parents, community leaders, and healthcare providers in Ohio Appalachia. Vaccine 2009, 27:3945-3952.
19. Reiter P.L., Katz M.L., Ferketich M.L., Ruffin M.T., Paskett E.D. Appalachian self-identity among women in Ohio Appalachia. Journal of Rural Community Psychology 2009, E12.
20. Dempsey A.F., Abraham L.M., Dalton V., Ruffin M. Understanding the reasons why mothers do or do not have their adolescent daughters vaccinated against human papillomavirus. Ann. Epidemiol. 2009, 19:531-538.
21. Barnack J.L., Reddy D.M., Swain C. Predictors of parents' willingness to vaccinate for human papillomavirus and physicians' intentions to recommend the vaccine. Womens Health Issues 2010, 20:28-34.
22. Allen J.D., Othus M.K., Shelton R.C., Li Y., Norman N., Tom L., et al. Parental decision making about the HPV vaccine. Cancer Epidemiol. Biomarkers Prev. 2010, 19:2187-2198.
23. Chao C., Slezak J.M., Coleman K.J., Jacobsen S.J. Papanicolaou screening behavior in mothers and human papillomavirus vaccine uptake in adolescent girls. Am. J. Public Health 2009, 99:1137-1142.
24. Vaccination coverage among adolescents aged 13-17 years - United States, 2007. Morb. Mortal. Wkly Rep. 2008, 57:1100-1103.
25. National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. Morb. Mortal. Wkly Rep. 2010, 59:1018-1023.
26. Sondik E.J., Huang D.T., Klein R.J., Satcher D. Progress toward the healthy people 2010 goals and objectives. Annu. Rev. Public Health 2010, 31:271-281. 4 p. following 81.
27. Hall H.I., Rogers J.D., Weir H.K., Miller D.S., Uhler R.J. Breast and cervical carcinoma mortality among women in the Appalachian region of the U.S., 1976-1996. Cancer 2000, 89:1593-1602.
28. Cancer Death Rates - Appalachia, 1994-1998. Morb. Mortal. Wkly Rep. 2002, 51:527-529.
29. Solomon D., Davey D., Kurman R., Moriarty A., O'Connor D., Prey M., et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002, 287:2114-2119.
30. Stevens M.P., Garland S.M., Rudland E., Tan J., Quinn M.A., Tabrizi S.N. Comparison of the Digene Hybrid Capture 2 assay and Roche AMPLICOR and LINEAR ARRAY human papillomavirus (HPV) tests in detecting high-risk HPV genotypes in specimens from women with previous abnormal Pap smear results. J. Clin. Microbiol. 2007, 45:2130-2137.
31. Schalasta G., Rosenthal T., Grothe M. Roche AMPLICOR human papilloma virus (HPV) and LINEAR ARRAY HPV tests will profit from automated DNA extraction. Clin. Lab. 2007, 53:131-133.
32. Tiro J.A., Meissner H.I., Kobrin S., Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol. Biomarkers Prev. 2007, 16:288-294.
33. Reiter P.L., Katz M.L., Ferketich A.K., Ruffin M.T., Paskett E.D. Measuring cervical cancer risk: development and validation of the CARE risky sexual behavior index. Cancer Causes Control 2009, 20:1865-1871.
34. Paskett E.D, McLaughlin J.M., Reiter P.L., Lehman A.M., Rhoda D.A., Katz M.L., et al. Psychosocial predictors of adherence to risk-appropriate cervical cancer screening guidelines: a cross sectional study of women in Ohio Appalachia participating in the Community Awareness Resources and Education (CARE) project. Prev. Med. 2010, 50:74-80.
35. Brewer N.T., Fazekas K.I. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev. Med. 2007, 45:107-114.
36. Noakes K., Yarwood J., Salisbury D. Parental response to the introduction of a vaccine against human papilloma virus. Hum. Vaccin. 2006, 2:243-248.
37. Salz T., Gottlieb S.L., Smith J.S., Brewer N.T. The association between cervical abnormalities and attitudes toward cervical cancer prevention. J. Womens Health (Larchmt) 2010, 19:2011-2016.
38. McRee A.L., Brewer N.T., Reiter P.L., Gottlieb S.L., Smith J.S. The Carolina HPV Immunization Attitudes and Beliefs Scale (CHIAS): Scale Development and Associations with intentions to vaccinate. Sex. Transm. Dis. 2010, 37(4):234-239.
39. Ferris D.G., Waller J.L., Owen A., Smith J. Midadult women's attitudes about receiving the prophylactic human papillomavirus vaccine. J. Low. Genit. Tract Dis. 2007, 11:166-172.
40. Ferris D.G., Waller J.L., Owen A., Smith J. HPV vaccine acceptance among mid-adult women. J. Am. Board Fam. Med. 2008, 21:31-37.
41. Sanderson M., Coker A.L., Eggleston K.S., Fernandez M.E., Arrastia C.D., Fadden M.K. HPV vaccine acceptance among Latina mothers by HPV status. J. Womens Health (Larchmt) 2009, 18:1793-1799.